Table 1 Sequence and properties of the membrane-active peptides used.
Peptide | Source | Sequence | Residue | Net charge |
|---|---|---|---|---|
Melittin | Insect venom | GIGAVLKVLT TGLPALISWI KRKRQQ | 26 | + 6 |
CM15 | Synthetic hybrid | KWKLFKKIGA VLKVL | 15 | + 6 |
LL-37 | Human (skin, intestine, etc.) | LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES | 37 | + 7 |
FK-16 | LL-37-derived, synthetic | FKRIVQRIKD FLRNLV | 16 | + 5 |
Buforin I | Frog stomach, histone-derived, Human gastric fluida | AGRGKQGGKV RAKAKTRSSR AGLQFPVGRV HRLLRKGNY a | 39 | + 13 |
Dhvar4 | Human saliva histatin-derived synthetic | KRLFKKLLFS LRKY | 14 | + 7 |
Macropin 1 | Insect venom | GFGMALKLLK KVL | 13 | + 4 |
Lasioglossin III | Insect venom | VNWKKVLGKI IKVAK | 15 | + 3 |
Temporin-La | Frog skin | LLRHVVKILE KYL | 13 | + 6 |